Key result
Connective tissue diseases are linked to increased augmentation index as a potential cardiovascular prognostic factor.
Why the study?
Does the augmentation index (AIx) predict cardiovascular disease risk in patients with connective tissue diseases?
Population
Patients with connective tissue diseases (CTDs)
Comparison
Pulse wave analysis using augmentation index vs Healthy control group
Design
Review
Authors
Loading...
AIx may support cardiovascular risk assessment in connective tissue diseases; leaves open its prognostic utility pending prospective validation.
Does the augmentation index (AIx) predict cardiovascular disease risk in patients with connective tissue diseases?
Augmentation index (AIx) is a promising non-invasive surrogate marker for evaluating cardiovascular risk and arterial stiffness in patients with connective tissue diseases.
Choi et al. (2017) conducted a review in Connective tissue diseases. Augmentation index (AIx) vs. Healthy controls was evaluated. Augmentation index is increased in patients with connective tissue diseases compared to healthy controls and is expected to be a prognostic factor for cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: